SOURCE: INC Research

INC Research

April 07, 2011 09:00 ET

INC Research Sponsors FierceBiotech Clinical Insights Executive Breakfast on Designing the Ideal Phase II Trial

Exclusive Gathering to Feature Expert Panel Offering Perspectives on the Latest Trends and Technologies for Mid-Stage Studies

SAN FRANCISCO, CA--(Marketwire - April 7, 2011) - INC Research, LLC, a therapeutically focused contract research organization (CRO) with a trusted process for delivering reliable results, is the lead sponsor of FierceBiotech's Fierce Clinical Insights Executive Breakfast on Wed., Apr. 13, from 7:30 a.m. - 9:00 a.m., held at the Hotel Nikko in San Francisco.

Executives from Pfizer, the Gladstone Institute of Cardiovascular Disease, Theravance, Calithera Biosciences, and Exelixis will be discussing the issues facing today's drug developers as they attempt to design and execute an ideal Phase II clinical trial. The unique format of the event will give attendees an opportunity to exchange their ideas with top industry executives about the latest trends and technologies being applied in mid-stage studies. John Carroll, executive editor of FierceBiotech, will be moderating the expert panel.

For most biotechs, Phase II remains right at the crossroads of success and failure. Getting there and navigating all the pitfalls that await any developer in the process is crucial to obtaining critical proof of concept data. This event will provide valuable insight for biotechs looking for new ways to improve their odds of success in leading them to the threshold of Phase III and the best possible alliance for their lead products.

To register for FierceBiotech's Fierce Clinical Insights Executive Breakfast, click here.

Download the INC Research Foresight article, "The Secret to Keeping Phase II Trials on Track? A Targeted Multi-Country Strategy" or visit the website for more information on its clinical trials services, therapeutic expertise and Trusted Process.

About INC Research, LLC.
INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women's health trials. The company's Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information please visit or follow us at @inc_research.

Contact Information